NCT04603521View on ClinicalTrials.gov

Patients' Long-Term Survival of Obstructive Hypertrophic Cardiomyopathy (HCM)

CompletedOBSERVATIONAL
Enrollment

325

Participants

Timeline

Start Date

October 20, 2020

Primary Completion Date

March 14, 2022

Study Completion Date

April 26, 2022

Conditions
CardiomyopathyObstructive Hypertrophic Cardiomyopathy
Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT04603521 - Patients' Long-Term Survival of Obstructive Hypertrophic Cardiomyopathy (HCM) | Biotech Hunter | Biotech Hunter